Allied Market Research
Loading...
0
Upcoming Allied Market Research
2021
Amylin Analogs Market

Amylin Analogs Market by Diabetes Type (Type I Diabetes, Type II Diabetes, Gestational Diabetes) and End User (Hospitals, Drug Stores, Pharmacy Stores, Online Pharmacy and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030

A12460
Pages: NA
Sep 2021 | 94 Views
   
Author(s) : Onkar Sumant
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Amylin Analogs Market

Request Now !

Amylin Analogs Market Outlook 2030:

Amylin is basically a peptide hormone that is inducted with pancreatic beta-cell and is thus deficient in diabetic population. The hormone acts as a satiety agent while delaying gastric emptying. It also assists the insulin in controlling post meal high glucose levels Amylin Analogs are thus injectable drugs used to treat both Type-I and Type-II diabetes. Advantages of using the drug include low blood sugar levels, weight loss, enhanced digestion and suppression in the release of glucagon from the stomach. However, there are a few side effects associated with the usage of amylin analogs including vomiting, nausea and heart burn. Some of the major amylin analogs are pramlintide, smylin, etc.

Amylin analogs market is segmented based on type of diabetes such Type I and Type II diabetes with Asia Pacific witnessing higher number of cases of the later and North America topping the former. With regards to end users, hospitals and pharmacy stores top the list owing to being avenues for highest sales. Lately, owing to COVID-19 restrictions and overall move towards ecommerce, online pharmacy sales have shot up significantly too.

Market Scope and Structure Analysis

Report Metric

Details

 Market Size Available for Years

 2020–2030

 Base Year Considered

 2020

 Forecast Period

 2021–2030

 Forecast Unit

 Value (USD)

 Segments Covered

 Diabetes Type, End User, and Region

 Regions Covered

 North America, Europe, Asia-Pacific, and LAMEA

 Companies Covered

Novo Nordisk, Sanofi, AstraZeneca, Boehringer Ingelheim, Eli Lilly & Company, Jardiance Ltd., Soliqua, Victoza, Lantus, Toujeo, Bydureon BCise, Trulicity


COVID-19 Impact Analysis

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the amylin analogs market.

Top Impacting Factors

  • Growing burden of diabetes on the industrialized economies around the world with their role as global players and the subsequent need of advanced therapeutic drugs towards its treatment is a major factor driving growth of amylin analogs market.
  • Impending unmet needs regarding advancements in healthcare infrastructure in high populace economies like India and China which experience higher diabetic population is another factor driving inception of new players in the industry and growth in overall amylin analogs market share.
  • Increasing number of awareness initiatives regarding diabetes, its types, causes and treatment by governments across the globe is yet another factor driving the amylin analogs market growth.
  • Shift of public policies towards developing enhanced healthcare supply chains owing to COVID-19 is prompting frequent product developments and clinical trials. This in turn is anticipated to affect amylin analogs market as well.
  • Adoption of ecommerce as an alternative to traditional pharmacy stores during times of COVID-19 and beyond is likely to increase sales of amylin analogs as Omni channel strategy holds the capability to provide the customer base with beyond expectation service levels.
  • However, higher cost of development and distribution associated with the drug is likely to hamper growth especially in rogue nations with less support from the ruling government.

Key Market Trends

  • North America is likely to retain its position as the market leader when it comes to amylin analogs owing to higher proportion of diabetic patients combined with higher levels of disposable income, higher awareness and basic healthcare facilities at the disposal.
  • Amylin analogs market is forecasted to increase two fold in Asia Pacific region in the next 1- years owing to rise in demand from Type I diabetic population residing in the region coupled with advancements in analog technology through massive collaborations between regional players such as Hindanol, etc.
  • Recently, Novo Novardisk announced their new amylin analog product by the name of Rybelsus towards treatment of Type-2 diabetic patients.
  • In 2019, Novo Novardisk also announced opening of a new amylin analog manufacturing facility in Kalundborg, Denmark for rapid penetration into North European market.
  • Research and development is also underway regarding development of long term solution for treatment of diabetes. This includes development of artificial pancreas with the idea gaining rapid popularity owing to support from United States Food and Drug Administration (USFDA)

Key Segments Covered

Segment

Subsegment

 Diabetes Type

  • Type I Diabetes
  •  Type II Diabetes
  •  Gestational Diabetes

 End User

  • Hospitals
  • Drug Stores
  • Pharmacy Stores
  • Online Pharmacy
  • Others

 Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA


Key Benefits of the Report

  • This study presents the analytical depiction of the amylin analogs industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the amylin analogs market share.
  • The current market is quantitatively analyzed from 2020 to 2030 to highlight the amylin analogs  growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.

Questions Answered in the Amylin Analogs Report

  • Which are the leading players active in the amylin analogs market?
  • How is each segment of the market expected to grow during the forecast period?
  • What are the adoption trends for the amylin analogs market in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What are the impacts of COVID-19 in the industry?
  • What is amylin analogs?
  • What is the amylin analogs  market prediction in the future?
  • What are the current trends and predicted trends?
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
PURCHASE OPTIONS

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.

RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

REQUEST TOC/SAMPLE

OR

Purchase Full Report of
Amylin Analogs Market

Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $9,995  $8,996
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers